Acute Aortic Dissection
15
3
5
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (15)
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
Immune-Inflammatory Markers in Aortic Dissection
Coagulation in Acute Aortic Dissection
Thoraflex Hybrid Post-Market Study
Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.
PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
A Triple-branched Stent Graft for Aute Debakey Type I Dissection Surgery
A Pilot Study of Sivelestat Sodium to Shorten Mechanical Ventilation in Acute Aortic Dissection
Perioperative Eosinophils Their Recovery in Type A Acute Aortic Dissection Prognosis
Blood Biomarker Discovery by Raman Spectroscopy in Acute Aortic Dissection
Prospective Multicenter Study for Early Evaluation of Acute Chest Pain
Triple-branch Stent Graft Placement for the Treatment of Acute DeBakey I Aortic Dissection
Correlation Between Sex and Prognosis of Acute Aortic Dissection in the Chinese Population
Triple-branch Stent Graft Placement and Total-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection
Mechanism and Early Intervention Research on ALI During Emergence Surgery of Acute Stanford A Aortic Dissection